Macrophage-Driven iTreg Cell Induction in the Lung Parenchyma

Lung-resident macrophages are instrumental in establishing local immune tolerance by directly inducing Foxp3+ inducible regulatory T cells (iTreg cells) within the lung parenchyma. Unlike conventional dendritic cells that often promote effector responses, these tissue macrophages function as specialized tolerogenic antigen-presenting cells. Upon inhalation of harmless antigens, they efficiently capture and process the antigens without requiring exogenous stimulation. When presented to naive CD4+ T cells, this interaction leads to robust Foxp3 expression, resulting in the generation of functional iTreg cells. This process is intrinsic to the macrophage phenotype and does not rely on prior activation or inflammatory cues.

The induction of iTreg cells occurs predominantly in the lung tissue itself, rather than in draining lymph nodes. Evidence from adoptive transfer experiments in CCR7-deficient and MHC class II-deficient mice shows that Foxp3+ T cell differentiation proceeds normally despite impaired migration to lymphoid organs or defective antigen presentation by endogenous APCs. This indicates that the lung parenchyma provides a sufficient microenvironment for regulatory programming. Moreover, immunofluorescent imaging reveals direct physical contact between donor T cells and resident macrophages within lung tissue, supporting the notion of localized antigen presentation and regulation.6-(4-Hydroxyphenoxy)hexyl Purity

Even activated T cells primed in lymph nodes can be redirected toward a regulatory fate upon encounter with lung macrophages.Tetrafluorophthalic acid MedChemExpress In co-culture systems, T cells previously stimulated by mediastinal lymph node dendritic cells were reprogrammed into Foxp3+ iTreg cells when exposed to antigen-loaded lung macrophages.PMID:35168710 This demonstrates the macrophage’s capacity to act as a secondary or even tertiary APC, capable of modifying ongoing immune responses. However, this plasticity is time-sensitive; prolonged activation reduces the ability of macrophages to induce regulatory differentiation, suggesting a narrow window of opportunity for tolerogenic intervention.

The functional significance of this mechanism is underscored by its protective role in allergic inflammation. Administration of OVA-pulsed lung macrophages into naive mice prevents subsequent development of eosinophilic lung inflammation, mucus production, and airway hyperreactivity following allergen challenge. This protection correlates with increased numbers of Foxp3+ Treg cells in the lungs, particularly the CD62Llo subset, which likely represents antigen-specific regulatory cells. In contrast, unpulsed macrophages fail to induce tolerance and instead permit full-blown Th2 responses.

These findings reveal that lung-resident macrophages are not merely phagocytic sentinels but active orchestrators of immune homeostasis. Their ability to initiate iTreg cell differentiation directly in the lung tissue positions them as central players in maintaining mucosal tolerance. Targeting their regulatory function—through pharmacological enhancement or cellular therapy—may offer a novel strategy for preventing or treating allergic asthma by restoring intrinsic mechanisms of immune control.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com